Stonehenge Growth Capital
7
2M
6
0.29
3
0.14
3
- Areas of investment
Summary
Stonehenge Growth Capital is the famous VC, which was founded in 1999. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Dallas.
The increased amount of exits for fund were in 2017. The typical startup value when the investment from Stonehenge Growth Capital is 5-10 millions dollars. The fund is generally included in less than 2 deals every year. The high activity for fund was in 2017. Opposing the other organizations, this Stonehenge Growth Capital works on 31 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 1 - 5 millions dollars. Speaking about the real fund results, this VC is 40 percentage points more often commits exit comparing to other organizations.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the Stonehenge Growth Capital, startups are often financed by Stonehenge Capital, McKnight Foundation, Connecticut Innovations. The meaningful sponsors for the fund in investment in the same round are Connecticut Innovations, Trillium Group, Benslie International Ltd. In the next rounds fund is usually obtained by Stonehenge Capital, Norwest Venture Partners, HighCape Partners.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight PosiGen, iCardiac Technologies, PCC Technology Group. The fund has no exact preference in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Care. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 3
- Exits
- 3
- Rounds per year
- 0.29
- Follow on index
- 0.14
- Investments by industry
- Health Care (4)
- Biotechnology (3)
- Medical Device (3)
- Medical (2)
- Life Science (1) Show 16 more
- Investments by region
-
- United States (7)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 1M
- Group Appearance index
- 0.57
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
iCardiac Technologies | 14 Nov 2007 | Biotechnology, Health Care, Life Science, Biopharma | Early Stage Venture | 0 | United States, New York, Rochester |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.